We are live on ! Find out more
WST icon

West Pharmaceutical
WST

294 hedge funds and large institutions have $5.45B invested in West Pharmaceutical in 2017 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 114 increasing their positions, 97 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $351K | Put options by funds: $231K

42% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 31

18% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 97

2% more funds holding

Funds holding: 287 → 294 (+7)

0.69% less ownership

Funds ownership: 91.68% → 90.99% (-0.69%)

4% less capital invested

Capital invested by funds: $5.69B → $5.45B (-$244M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
294
Holders Change
+7
Holders Change %
+2.44%
% of All Funds
7.32%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
44
Increased
114
Reduced
97
Closed
31
Calls
$351K
Puts
$231K
Net Calls
+$120K
Net Calls Change
+$2.83M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$480M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$32.8M
3
Wells Fargo
Wells Fargo
California
+$22M
4
Select Equity Group
Select Equity Group
New York
+$16M
5
JP Morgan Chase
JP Morgan Chase
New York
+$15.6M

Top Sellers

Rank Fund Capital Flow
1
KI
Kalmar Investments
Delaware
-$48.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$43.1M
3
GIM
Granahan Investment Management
Massachusetts
-$26.7M
4
RCG
Ruane, Cunniff & Goldfarb
New York
-$26.3M
5
BAMCO Inc
BAMCO Inc
New York
-$19.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
151
Stifel Financial
Missouri
$1.14M -$5.99M -71,621 -84%
KPCM
152
Kings Point Capital Management
New York
$1.11M -$4.7M -56,235 -80%
PP
153
Paloma Partners
Connecticut
$1.09M +$1.12M +13,353 New
URS
154
Utah Retirement Systems
Utah
$1.08M – – –
Balyasny Asset Management
155
Balyasny Asset Management
Illinois
$1.08M +$576K +6,893 +109%
TI
156
Trexquant Investment
Connecticut
$1.06M +$840K +10,040 +345%
NMIMC
157
Northwestern Mutual Investment Management Company
Wisconsin
$1.03M +$1.09K +13 +0.1%
JG
158
Jefferies Group
New York
$981K +$1.01M +12,020 New
HIM
159
Hillsdale Investment Management
Ontario, Canada
$979K – – –
NBC
160
Neuberger Berman Canada
Ontario, Canada
$979K +$749K +8,959 +295%
SAA
161
Southeast Asset Advisors
Georgia
$959K – – –
CT
162
Cambridge Trust
Massachusetts
$958K +$159K +1,903 +19%
OAM
163
Oppenheimer Asset Management
New York
$952K +$975K +11,662 New
AB
164
Amalgamated Bank
New York
$944K -$193K -2,314 -17%
PA
165
Profund Advisors
Maryland
$937K +$60K +718 +7%
GC
166
Guggenheim Capital
Illinois
$919K +$17K +203 +2%
CCA
167
Conestoga Capital Advisors
Pennsylvania
$908K +$930K +11,125 New
Bessemer Group
168
Bessemer Group
New Jersey
$892K -$7.69K -92 -0.8%
COPPSERS
169
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$873K -$11.2K -134 -1%
Natixis Advisors
170
Natixis Advisors
Massachusetts
$861K -$15.1K -181 -2%
SB
171
Suntrust Banks
Georgia
$843K +$53.4K +639 +7%
CAM
172
Capstone Asset Management
Texas
$829K +$19.6K +234 +2%
Barclays
173
Barclays
United Kingdom
$827K +$235K +2,814 +38%
Pacer Advisors
174
Pacer Advisors
Pennsylvania
$788K +$130K +1,549 +19%
SAM
175
Securian Asset Management
Minnesota
$766K +$23.8K +285 +3%
5 6
7
8 9

WST Hedge Fund Activity: Q1 2017 in Review

294 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q1 2017, worth a combined $5.45B — down 4.3% from $5.69B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new WST positions and 31 closed out — a net gain of 13 holders — while 114 added to existing stakes and 97 trimmed.

The largest buyer was BlackRock, adding an estimated $480M. The largest seller was Kalmar Investments, cutting an estimated $48.3M.

  • 294 institutional investors held West Pharmaceutical (WST) as of Q1 2017, up from 287 in Q4 2016.
  • Funds reported $5.45B of West Pharmaceutical stock for Q1 2017, down 4.3% quarter-over-quarter.
  • 44 funds opened new West Pharmaceutical positions in Q1 2017 and 31 closed out, a net change of +13 holders.
  • The largest West Pharmaceutical buyer in Q1 2017 was BlackRock, an estimated $480M added.
  • The largest West Pharmaceutical seller in Q1 2017 was Kalmar Investments, an estimated $48.3M sold.

Based on aggregated 13F filings for Q1 2017.